Portfolio
Overview

Watchlist
Overview


more

Portfolios Overview New Portfolio
Demo Portfolio
$75,350.00
Total Gain % 149.43%
Total Gain $25,350.00
Total Realised % 0.00%
Total Realised $0.00
Back
Watchlists Overview New Watchlist
Targets
33 Average Rating
Number of Companies 3
Date Created 04 Mar, 2015
Back
Portfolio Summary
Demo Portfolio
Market Value $75,350.00
Total Gain $25,350.00
(149.43%)
Value $42,315.00
Close Price (13 Apr) $141.05
Unrealised P/L (%) 149.40%
Unrealised P/L $25,350.00
Total $75,350.00
$25,350.00
Back
Back
Watchlist Summary
Targets
Short Name TGTS
Date Created 04 Mar, 2015
Current Price $64.95
Added Price $43.06
STRIDE Rating 36
Value Change (%) 50.85%
Current Price $33.88
Added Price $34.64
STRIDE Rating 25
Value Change (%) -2.19%
Current Price $26.74
Added Price $29.27
STRIDE Rating 35
Value Change (%) -8.63%
Total Buy0
Total Hold0
Total Sell3
Back
Back
Filter
Include in Feed
My Portfolios
My Watchlists
STRIDE Lists
Filter Feed By
STRIDE 3D VI
Activity
Upcoming
Warning
Back
Company FilterClear All
Filter by Company Descriptions
Filter by STRIDE Scores
Strength
to
Timing
to
Returns
to
Intrinsic Value
to
Dividends
to
Earnings Predictability
to
Rating
to
Back
Options
Add To Watchlist
Company Info (Sample)
Options
Add To Watchlist

Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation
Pharmaceuticals, Biotechnology and Life Sciences : Life Sciences Tools and Services.
4133 on Taiwan Stock Exchange.
Price in Taiwan Dollar, all financial data originally reported in Taiwan Dollar.
The business last filed accounts on the 14 Nov, 2016.
Company website: www.abnova.com
Show Company Details
STRIDE Rating
00
Buy
Hold
Sell
Taiwan, Micro Cap
Market Capitalisation: NT$2,033.94M
Total Enterprise Value: Get a demo
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies in Taiwan. It offers DNA and RNA, siRNA/chimera, proteins/peptides, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hydridization products, circulating rare cells, and various systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. The company also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, and IHC/pathology antibodies. In addition, the company’s integrated solutions and services includee gene synthesis and cytogenetics; peptide synthesis/mapping, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan. Read More
Price & Valuation Info
Price Quote on 14th Apr '17
NT$34.55 -0.45(-1.29%)
52 Week Range
27.15
39.49
Interactive STRIDE chart with history.
Only available to subscribers.
Get a demo now.
Performance
1 month -1.60 (-4.43%)
year-to-date -2.20 (-5.99%)
1 year 4.63 (15.49%)
Show More Valuation Info
Momentum
vs 52week high 87%
vs 50d SMA 95%
vs 200d SMA97%
STRIDE Valuations
Consider Buy Get a demo
Fair Value Get a demo
Consider Sell Get a demo
Price/Adj. Earnings Get a demo
Price/Adj FCF Get a demo
Price/Adj. TBV Get a demo
Forecast Growth Get a demo
Other Valuations
Price/Book Get a demo
Price/Tangible Book Get a demo
Price/Sales Get a demo
Price/Earnings Get a demo
Price/Free Cashflow Get a demo
EV/EBITDA Get a demo
Dividend Yield Get a demo
Volume
Ave. Vol. last 6 months
Hide Extra Info
Scores
S
Strength
T
Timing
R
Returns
I
Intrinsic Value
D
Dividends
E
Earnings Predictability
Other Metrics
Altman Z-Score (Bankruptcy)
Greenblatt Rank (Magic Formula)
Piotroski F-Score (Financial Health)
Beneish M-Score (Earnings Manipulation)
Financials Get a demo
To The Top
Company Options
Add To Watchlist
Watchlists:
Targets
Options
Price Alert Email:
Price to alert at:*
When to alert:*
Cancel
Save
Price Alerts Configured:
Back

Portfolio
Overview

Watchlist
Overview

Feed
Filter


more